Breakthrough in Pediatric Brain Cancer Research: Plus Therapeutics Secures $3 Million DoD Award. In an unprecedented move that signals a new era for cancer treatment, Plus Therapeutics, Inc., a trailblazer in the development of targeted radiotherapeutics, has been awarded a $3 million grant by the Department of Defense (DoD) through its Congressionally Directed Medical Research Programs (CDMRP). This s...
$Plus Therapeutics(PSTV.US)$Plus Therapeutics Announces Validation & Clinical Implementation Of CSF-01 Leptomeningeal Cancer Cell Diagnostic Benzinga· 3 mins ago
$Plus Therapeutics(PSTV.US)$Director Lenk Robert P purchased 2,000 shares of Common Stocks on Nov 15, 16, 2023 at an average price of $1.86 for a total value of $3,720.
Plus Therapeutics股票討論區
Therapeutics Company Secures $3M Department of Defense Award For Pediatric Brain Cancer Trials
In an unprecedented move that signals a new era for cancer treatment, Plus Therapeutics, Inc., a trailblazer in the development of targeted radiotherapeutics, has been awarded a $3 million grant by the Department of Defense (DoD) through its Congressionally Directed Medical Research Programs (CDMRP). This s...
Hmm!
Update
Benzinga· 3 mins ago
Interest Swelling
Salvation is coming, perhaps !
1.3m share offering at 1.83 love the dips thanks for the offering dips
nice dips
Insider buy
Nov 17 low priced watchlists
Useless short
Where is the short ??? I wan buy cheap share !!!!
暫無評論